Abstract

Lorazepam 1 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2022 - Volume 26, Number 2

Page(s): 143

Download in electronic PDF format for $75
  • Lorazepam 1 mg/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Lorazepam 1 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • lorazepam
  • benzodiazepine
  • sedation
  • sedative
  • anxiety disorders
  • cancer chemotherapy-induced nausea and vomiting
  • anterograde amnesia

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • GASTROENTEROLOGY
  • MENTAL HEALTH
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2022
Pg. 143
Lorazepam 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 319
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 317
Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 161
Lorazepam 4-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 420
Lorazepam 1-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 321
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 168-175
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2000
Pg. 250-251
Nausea and Vomiting in Hospice Patients
Author(s): Boomsma Diane
Mar/Apr 2022
Pg. 140
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2006
Pg. 95-98
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Author(s): Moon Richard B
Mar/Apr 2022
Pg. 146
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 60
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 344-347
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes
Author(s): Anderson Collin R, Halford Zachery, MacKay Mark
Nov/Dec 2021
Pg. 500
Domperidone 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 235-237
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Xu Quanyun A